On the validity of single tests,two-test combinations and the full Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in detecting patients with cognitive impairment
Restricted accessResearch articleFirst published online December, 2020
On the validity of single tests,two-test combinations and the full Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in detecting patients with cognitive impairment
The international standard to screen for cognitive impairment in multiple sclerosis (MS) is BICAMS (Brief International Cognitive Assessment for MS). However, with an application time of approximately 20 minutes, the battery might be too time consuming from a pragmatic perspective of a routine examination.
Objectives:
To examine the relative sensitivity and specificity of a BICAMS short version and its validity compared to the total battery.
Methods:
The German BICAMS version was applied comprising the Symbol Digit Modalities Test (SDMT), the Brief Visuospatial Memory Test–Revised (BVMT-R) and the Rey Auditory Verbal Learning Test (RAVLT; German VLMT). Single tests and two-test combinations were compared regarding conformity with the total battery.
Results:
Examining 1320 MS patients, the two-test combination of SDMT-BVMT-R was the most sensitive (92.7%) to impairment and showed the strongest agreement with the total battery (κ = 0.95). Performing binary logistic regression analyses, this combination was also validated by its association with employment status.
Conclusion:
Application of the total BICAMS battery should be the goal to strive for. However, in time-restricted clinical settings, the combined application of SDMT and BVMT-R is a recommendable alternative with an application time of 10 minutes, while single tests alone are not sufficiently sensitive.
AchironAChapmanJMagalashviliD, et al. Modeling of cognitive impairment by disease duration in multiple sclerosis : A cross-sectional study. PLoS ONE2013; 8(8): e71058.
2.
RuanoLPortaccioEGorettiB, et al. Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes. Mult Scler2017; 23(9): 1258–1267.
3.
ArchibaldCJFiskJD.Information processing efficiency in patients with multiple sclerosis. J Clin Exp Neuropsychol2000; 22(5): 686–701.
4.
PöttgenJStephanJGoldSM, et al. Perceived and objective attentional deficits in multiple sclerosis. Zeitschrift Für Neuropsychol2015; 26: 171–178.
5.
Cerezo GarciaMMartin PlasenciaPAladro BenitoY. Alteration profile of executive functions in multiple sclerosis. Acta Neurol Scand2015; 131(5): 313–320.
6.
ChiaravallotiNDDelucaJ.Cognitive impairment in multiple sclerosis. Lancet Neurol2008; 7: 1139–1151.
7.
HulstHESchoonheimMMVan GeestQ, et al. Memory impairment in multiple sclerosis: Relevance of hippocampal activation and hippocampal connectivity. Mult Scler2015; 21(13): 1705–1712.
8.
RaoSMLeoGJBernardinL, et al. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology1991; 41: 685–691.
9.
DeloireMSABonnetMCSalortE, et al. How to detect cognitive dysfunction at early stages of multiple sclerosis. Mult Scler2006; 12(4): 445–452.
10.
AmatoMPZipoliVPortaccioE.Cognitive changes in multiple sclerosis. Expert Rev Neurother2008; 8: 1585–1596.
11.
KobeltGThompsonABergJ, et al. New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler J2017; 23: 1123–1136.
12.
LangdonDAmatoMBoringaJ, et al. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler2012; 18(6): 891–898.
13.
BenedictRHBAmatoMPBoringaJ, et al. Brief International Cognitive Assessment for MS (BICAMS): International standards for validation. BMC Neurol2012; 12: 55.
14.
CorfieldFLangdonD.A systematic review and meta-analysis of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS). Neurol Ther2018; 7(2): 1–20.
15.
FilserMSchreiberHPöttgenJ, et al. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): Results from the German validation study. J Neurol2018; 265: 2587–2593.
16.
PortaccioEGorettiBZipoliV, et al. A short version of Rao’s brief repeatable battery as a screening tool for cognitive impairment in multiple sclerosis. Clin Neuropsychol2009; 23(2): 268–275.
17.
GromischESPortnoyJGFoleyFW.Comparison of the abbreviated minimal assessment of cognitive function in multiple sclerosis (aMACFIMS) and the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). J Neurol Sci2018; 388: 70–75.
18.
SmithA. The symbol-digit modalities test: A neuropsychologic test of learning and other cerebral disorders. In: HelmuthJ (ed.) Learning disorders. 3rd ed.Seattle, WA: Taylor & Franchise, 1968.
19.
DelisDCKramerJHKaplanE, et al. California verbal learning test (CVLT-II) adult version: Manual. 2nd ed.San Antonio, TX: Psychological Corporation, 2000.
BenedictRHBDeLucaJPhillipsG, et al. Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis. Mult Scler2017; 23(5): 721–733.
22.
SchmidtM.Rey auditory verbal learning test: A handbook. Los Angeles, CA: Western Psychological Services, 1996.
SchererPBaumKBauerH, et al. Normierung der Brief Repeatable Battery of Neuropsychological tests (BRB-N) für den deutschsprachigen Raum. Anwendung bei schubförmig remittierenden und sekundär progredienten Multiple-sklerose-patienten. Nervenarzt2004; 75: 984–990.
25.
DusankovaJBKalincikTHavrdovaE, et al. Cross cultural validation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Clin Neuropsychol2012; 26(7): 1186–1200.
26.
RuetABrochetB.Cognitive assessment in patients with multiple sclerosis: From neuropsychological batteries to ecological tools. Ann Phys Rehabil Med. Epub ahead of print 17February2018. DOI: 10.1016/j.rehab.2018.01.006.
27.
McHughML.Interrater reliability: The kappa statistic. Biochem Medica2012; 22: 276–282.
28.
RiceMEHarrisGT.Comparing effect sizes in follow-up studies: ROC area, Cohen’s d, and r. Law Hum Behav2005; 29(5): 615–620.
29.
CohenJ.Statistical power analysis for the behavioral sciences. 2nd ed.Mahwah, NJ: Lawrence Erlbaum Associates, 1988.
30.
PlancheVGibelinMCregutD, et al. Cognitive impairment in a population-based study of patients with multiple sclerosis: Differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis. Eur J Neurol2016; 23(2): 282–289.
31.
FischerMKunkelABublakP, et al. How reliable is the classification of cognitive impairment across different criteria in early and late stages of multiple sclerosis. J Neurol Sci2014; 343(1–2): 91–99.
32.
Van SchependomJD’hoogheMBCleynhensK, et al. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis. Eur J Neurol2014; 21(9): 1219–1225.e71.
33.
ParmenterBAWeinstock-GuttmanBGargN, et al. Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test. Mult Scler2007; 13(1): 52–57.
34.
SumowskiJFBenedictREnzingerC, et al. Cognition in multiple sclerosis. Neurology2018; 90: 1–11.
35.
HoutchensMKBenedictRHBKillianyR, et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology2007; 69(12): 1213–1223.
